Farmer Brothers reports fourth quarter and full year fiscal 2024 financial results
September 12, 2024 16:05 ET
|
Farmer Bros. Co.
Farmer Bros. Co. (NASDAQ: FARM) reports its fourth quarter and full year fiscal 2024 financial results for the period ended June 30, 2024.
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 12, 2024 16:05 ET
|
Ocular Therapeutix, Inc.
BEDFORD, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to improving vision in the real world through the...
IBEX Announces Record Fourth Quarter and Fiscal Year 2024 Financial Results
September 12, 2024 16:05 ET
|
Ibex Limited
Record full-year Net Income, EPS, Adjusted Net Income, Adjusted EPS, and Free Cash Flow18 new client relationships won primarily with retail, healthcare, and gaming companies, compared to 10 in the...
Tilray Brands Completes Acquisition of Atwater Brewery From Molson Coors Beverage Company
September 12, 2024 16:05 ET
|
Tilray Brands, Inc.
Atwater Brewery from Molson Coors joins Tilray Brands’ beverage portfolio which includes leading craft beer, spirits, and non-alcohol beverage brands.
Workhorse Joins FedEx Forward Service Provider Summit as Presidential Exhibitor, Showcasing W56 Electric Vehicle
September 12, 2024 16:05 ET
|
Workhorse Group, Inc.
CINCINNATI, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to...
Globus Maritime Limited Reports Financial Results for the Second Quarter and Six-month period ended June 30, 2024
September 12, 2024 16:05 ET
|
Globus Maritime Limited
GLYFADA, Greece, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Globus Maritime Limited (“Globus”, the “Company”, “we”, or “our”) (NASDAQ: GLBS), a dry bulk shipping company, today reported its unaudited...
Cidara Therapeutics Restructures Workforce to Focus on Planned Clinical Development of CD388
September 12, 2024 16:05 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC)...
AVITA Medical to Present at 2024 Cantor Global Healthcare Conference
September 12, 2024 16:05 ET
|
AVITA Medical
AVITA Medical to present at the 2024 Cantor Global Healthcare Conference on September 18, 2024, at 9:10 a.m. Eastern Time.
Immuneering Announces Positive Initial Phase 2a Data Including Complete and Partial Responses with IMM-1-104 in Combination with Chemotherapy in First-Line Pancreatic Cancer Patients
September 12, 2024 16:05 ET
|
Immuneering Corporation
Immuneering Announces Positive Initial Phase 2a Data Including Complete and Partial Responses with IMM-1-104 in Combination with Chemotherapy in First-Line
Immunocore to present at the 2024 Cantor Global Healthcare Conference
September 12, 2024 16:05 ET
|
Immunocore Holdings plc
Immunocore to present at the 2024 Cantor Global Healthcare Conference (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 12 September 2024) Immunocore Holdings plc (Nasdaq:...